Effectiveness of Dry Needling for Improving Gait in the Patient With Multiple Sclerosis (DRYNEEDEM)
Multiple Sclerosis
About this trial
This is an interventional treatment trial for Multiple Sclerosis
Eligibility Criteria
Inclusion Criteria: Having been diagnosed with Multiple Sclerosis in a period of more than two years before the study starts Participate voluntarily and sign the informed consent. Suffering from some type of hypertonia or spasticity in MMII that makes walking difficult, measured with Expanded Disability Status Scale>2 (Pyramidal section >2) Age from 18 to 60 years old. Not having phobia of needles. Exclusion Criteria: Not signing the informed consent. Having a phobia of needles. Presenting an outbreak at the start of the study or having presented any outbreak up to two months before the start of the study.
Sites / Locations
- Hospital Universitario de CanariasRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
dry needling
placebo
The intervention group will have a single session of dry nedling application in the medial gastrocnemius + usual care (physiotherapy)
The control group will have a single session of sham dry nedling in the medial gastrocnemius + usual care (physiotherapy)